Terumo Corporation (TRUMY)
USD 19.28
(-2.92%)
USD 19.28
(-2.92%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 140.09 Billion JPY | 19.4% |
| 2023 | 117.33 Billion JPY | 1.18% |
| 2022 | 115.96 Billion JPY | 17.86% |
| 2021 | 98.38 Billion JPY | -11.05% |
| 2020 | 110.61 Billion JPY | 3.73% |
| 2019 | 106.63 Billion JPY | -1.76% |
| 2018 | 108.55 Billion JPY | 41.75% |
| 2017 | 76.57 Billion JPY | -6.27% |
| 2016 | 81.7 Billion JPY | 21.12% |
| 2015 | 67.45 Billion JPY | 3.32% |
| 2014 | 65.28 Billion JPY | 22.68% |
| 2013 | 53.21 Billion JPY | -15.6% |
| 2012 | 63.04 Billion JPY | 0.71% |
| 2011 | 62.6 Billion JPY | -1.07% |
| 2010 | 63.28 Billion JPY | 17.1% |
| 2009 | 54.03 Billion JPY | -19.27% |
| 2008 | 66.94 Billion JPY | 14.52% |
| 2007 | 58.45 Billion JPY | 21.15% |
| 2006 | 48.25 Billion JPY | 2.43% |
| 2005 | 47.1 Billion JPY | 28.53% |
| 2004 | 36.65 Billion JPY | 17.11% |
| 2003 | 31.29 Billion JPY | 11.63% |
| 2002 | 28.03 Billion JPY | -2.65% |
| 2001 | 28.8 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 30.66 Billion JPY | -21.42% |
| 2024 Q1 | 29.64 Billion JPY | 24.46% |
| 2024 Q2 | 36.84 Billion JPY | 24.3% |
| 2024 Q3 | 39.02 Billion JPY | 5.91% |
| 2024 FY | 190.91 Billion JPY | 62.71% |
| 2023 Q3 | 37.53 Billion JPY | 46.92% |
| 2023 Q1 | 30.42 Billion JPY | 41.49% |
| 2023 FY | 117.33 Billion JPY | 1.18% |
| 2023 Q4 | 23.81 Billion JPY | -36.55% |
| 2023 Q2 | 25.54 Billion JPY | -16.03% |
| 2022 Q3 | 28.59 Billion JPY | -3.46% |
| 2022 Q4 | 21.5 Billion JPY | -24.8% |
| 2022 Q1 | 36.23 Billion JPY | 56.76% |
| 2022 Q2 | 29.62 Billion JPY | -18.24% |
| 2022 FY | 115.96 Billion JPY | 17.86% |
| 2021 Q4 | 23.11 Billion JPY | -30.9% |
| 2021 FY | 98.38 Billion JPY | -11.05% |
| 2021 Q1 | 18.07 Billion JPY | -25.81% |
| 2021 Q2 | 23.75 Billion JPY | 31.42% |
| 2021 Q3 | 33.44 Billion JPY | 40.83% |
| 2020 Q2 | 29.98 Billion JPY | 2.79% |
| 2020 FY | 110.61 Billion JPY | 3.73% |
| 2020 Q4 | 24.36 Billion JPY | -10.11% |
| 2020 Q3 | 27.1 Billion JPY | -9.61% |
| 2020 Q1 | 29.16 Billion JPY | 3.57% |
| 2019 Q1 | 25.87 Billion JPY | -28.48% |
| 2019 FY | 106.63 Billion JPY | -1.76% |
| 2019 Q4 | 28.16 Billion JPY | -8.83% |
| 2019 Q3 | 30.89 Billion JPY | 42.31% |
| 2019 Q2 | 21.7 Billion JPY | -16.11% |
| 2018 Q3 | 24.47 Billion JPY | -14.84% |
| 2018 Q1 | 23.35 Billion JPY | 32.14% |
| 2018 FY | 108.55 Billion JPY | 41.75% |
| 2018 Q2 | 28.73 Billion JPY | 23.05% |
| 2018 Q4 | 36.17 Billion JPY | 47.82% |
| 2017 Q4 | 17.67 Billion JPY | -9.52% |
| 2017 Q3 | 19.53 Billion JPY | 8.44% |
| 2017 Q2 | 18.01 Billion JPY | -15.65% |
| 2017 FY | 76.57 Billion JPY | -6.27% |
| 2017 Q1 | 21.35 Billion JPY | 21.42% |
| 2016 FY | 81.7 Billion JPY | 21.12% |
| 2016 Q1 | 19.44 Billion JPY | 33.33% |
| 2016 Q2 | 19.65 Billion JPY | 1.05% |
| 2016 Q3 | 25.01 Billion JPY | 27.27% |
| 2016 Q4 | 17.58 Billion JPY | -29.68% |
| 2015 FY | 67.45 Billion JPY | 3.32% |
| 2015 Q3 | 19.87 Billion JPY | 17.79% |
| 2015 Q4 | 14.58 Billion JPY | -26.62% |
| 2015 Q1 | 16.11 Billion JPY | -5.42% |
| 2015 Q2 | 16.87 Billion JPY | 4.73% |
| 2014 Q3 | 17.78 Billion JPY | 3.73% |
| 2014 Q4 | 17.03 Billion JPY | -4.18% |
| 2014 FY | 65.28 Billion JPY | 22.68% |
| 2014 Q1 | 13.32 Billion JPY | 25.89% |
| 2014 Q2 | 17.14 Billion JPY | 28.6% |
| 2013 Q1 | 15.48 Billion JPY | 17.51% |
| 2013 Q4 | 10.58 Billion JPY | -26.57% |
| 2013 Q3 | 14.42 Billion JPY | 13.3% |
| 2013 Q2 | 12.72 Billion JPY | -17.79% |
| 2013 FY | 53.21 Billion JPY | -15.6% |
| 2012 Q1 | 17.37 Billion JPY | 19.8% |
| 2012 FY | 63.04 Billion JPY | 0.71% |
| 2012 Q2 | 17.25 Billion JPY | -0.71% |
| 2012 Q4 | 13.17 Billion JPY | -13.57% |
| 2012 Q3 | 15.24 Billion JPY | -11.66% |
| 2011 Q4 | 14.5 Billion JPY | -5.76% |
| 2011 FY | 62.6 Billion JPY | -1.07% |
| 2011 Q3 | 15.39 Billion JPY | -8.16% |
| 2011 Q2 | 16.76 Billion JPY | 5.1% |
| 2011 Q1 | 15.94 Billion JPY | 19.96% |
| 2010 Q1 | 16.47 Billion JPY | 93.56% |
| 2010 FY | 63.28 Billion JPY | 17.1% |
| 2010 Q3 | 17.43 Billion JPY | 8.49% |
| 2010 Q4 | 13.29 Billion JPY | -23.77% |
| 2010 Q2 | 16.07 Billion JPY | -2.44% |
| 2009 FY | 54.03 Billion JPY | -19.27% |
| 2009 Q4 | 8.51 Billion JPY | -39.5% |
| 2009 Q3 | 14.06 Billion JPY | -7.53% |
| 2009 Q2 | 15.21 Billion JPY | 0.0% |
| 2008 FY | 66.94 Billion JPY | 14.52% |
| 2007 FY | 58.45 Billion JPY | 21.15% |
| 2006 FY | 48.25 Billion JPY | 2.43% |
| 2005 FY | 47.1 Billion JPY | 28.53% |
| 2004 FY | 36.65 Billion JPY | 17.11% |
| 2003 FY | 31.29 Billion JPY | 11.63% |
| 2002 FY | 28.03 Billion JPY | -2.65% |
| 2001 FY | 28.8 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -12033364.465% |
| Ansell Limited | 129.3 Million USD | -108249.575% |
| Ansell Limited | 129.3 Million USD | -108249.575% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -449816.967% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 8779689.66% |
| Psykey, Inc. | -797.5 Thousand USD | 17566908.442% |
| ConvaTec Group Plc | 262.7 Million USD | -53229.273% |
| ConvaTec Group Plc | 262.7 Million USD | -53229.273% |
| Encision Inc. | -640.78 Thousand USD | 21863351.678% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 98791440.526% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 127441198.881% |
| Innovative MedTech Inc. | -4.27 Million USD | 3277907.882% |
| LifePoint, Inc. | -7.49 Million USD | 1869235.936% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 2162075.309% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -42453233.333% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 114001239.23% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 29981395.931% |
| SmileDirectClub, Inc. | -241.15 Million USD | 58193.516% |
| Sector 10, Inc. | -39.84 Thousand USD | 351611384.008% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -43733.862% |
| SheerVision, Inc. | 155.72 Thousand USD | -89963040.388% |
| United Health Products, Inc. | -2.42 Million USD | 5773590.556% |
| Vasamed, Inc. | 4.74 Million USD | -2954077.106% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 6106786.555% |
| Yubo International Biotech Limited | -1.2 Million USD | 11624172.889% |